A citation-based method for searching scientific literature

M C McFadyen, H L McLeod, F C Jackson, W T Melvin, J Doehmer, G I Murray. Biochem Pharmacol 2001
Times Cited: 133







List of co-cited articles
851 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor-specific expression of cytochrome P450 CYP1B1.
G I Murray, M C Taylor, M C McFadyen, J A McKay, W F Greenlee, M D Burke, W T Melvin. Cancer Res 1997
442
39

Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
B Rochat, J M Morsman, G I Murray, W D Figg, H L McLeod. J Pharmacol Exp Ther 2001
146
37



Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer.
M C McFadyen, M E Cruickshank, I D Miller, H L McLeod, W T Melvin, N E Haites, D Parkin, G I Murray. Br J Cancer 2001
110
21

17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
C L Hayes, D C Spink, B C Spink, J Q Cao, N J Walker, T R Sutter. Proc Natl Acad Sci U S A 1996
533
20

Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1.
G I Murray, W T Melvin, W F Greenlee, M D Burke. Annu Rev Pharmacol Toxicol 2001
263
18

Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
T Shimada, C L Hayes, H Yamazaki, S Amin, S S Hecht, F P Guengerich, T R Sutter. Cancer Res 1996
695
18


CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance.
V G Martinez, R O'Connor, Y Liang, M Clynes. Br J Cancer 2008
47
34

Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
Takashi Tokizane, Hiroaki Shiina, Mikio Igawa, Hideki Enokida, Shinji Urakami, Toshifumi Kawakami, Tatsuya Ogishima, Steven T Okino, Long-Cheng Li, Yuichiro Tanaka,[...]. Clin Cancer Res 2005
144
16


Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel.
Tristan M Sissung, Romano Danesi, Douglas K Price, Seth M Steinberg, Ronald de Wit, Muhammad Zahid, Nilesh Gaikwad, Ercole Cavalieri, William L Dahut, Dan L Sackett,[...]. Mol Cancer Ther 2008
69
21

Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2.
Stefaan Sansen, Jason K Yano, Rosamund L Reynald, Guillaume A Schoch, Keith J Griffin, C David Stout, Eric F Johnson. J Biol Chem 2007
346
15

Inhibitors of cytochrome P450 (CYP) 1B1.
Raphaël Dutour, Donald Poirier. Eur J Med Chem 2017
34
44

Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2.
T R Sutter, Y M Tang, C L Hayes, Y Y Wo, E W Jabs, X Li, H Yin, C W Cody, W F Greenlee. J Biol Chem 1994
430
14

Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.
Agnes A Walsh, Grazyna D Szklarz, Emily E Scott. J Biol Chem 2013
180
14

Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.
Neill J Horley, Kenneth J M Beresford, Tarun Chawla, Glen J P McCann, Ketan C Ruparelia, Linda Gatchie, Vinay R Sonawane, Ibidapo S Williams, Hoon L Tan, Prashant Joshi,[...]. Eur J Med Chem 2017
31
45

Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer.
S Marsh, G Somlo, X Li, P Frankel, C R King, W D Shannon, H L McLeod, T W Synold. Pharmacogenomics J 2007
94
13

Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Hitomi Takemura, Toshimasa Itoh, Keiko Yamamoto, Hiroyuki Sakakibara, Kayoko Shimoi. Bioorg Med Chem 2010
61
21

Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression.
Silvio Bandiera, Simone Weidlich, Volker Harth, Peter Broede, Yun Ko, Thomas Friedberg. Mol Pharmacol 2005
75
16


CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro.
Zhuangyan Zhu, Yaqin Mu, Caixia Qi, Jian Wang, Guoping Xi, Juncheng Guo, Ruoran Mi, Fuxi Zhao. Int J Mol Med 2015
36
33

Human CYP1B1 is regulated by estradiol via estrogen receptor.
Yuki Tsuchiya, Miki Nakajima, Satoru Kyo, Taro Kanaya, Masaki Inoue, Tsuyoshi Yokoi. Cancer Res 2004
201
11

MicroRNA regulates the expression of human cytochrome P450 1B1.
Yuki Tsuchiya, Miki Nakajima, Shingo Takagi, Takao Taniya, Tsuyoshi Yokoi. Cancer Res 2006
309
11


Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
E L Cavalieri, D E Stack, P D Devanesan, R Todorovic, I Dwivedy, S Higginbotham, S L Johansson, K D Patil, M L Gross, J K Gooden,[...]. Proc Natl Acad Sci U S A 1997
629
11


Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Vasilis P Androutsopoulos, Athanasios Papakyriakou, Dionisios Vourloumis, Demetrios A Spandidos. Bioorg Med Chem 2011
69
15

Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
F Peter Guengerich, Young-Jin Chun, Donghak Kim, Elizabeth M J Gillam, Tsutomu Shimada. Mutat Res 2003
122
11

Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
T Shimada, J Watanabe, K Kawajiri, T R Sutter, F P Guengerich, E M Gillam, K Inoue. Carcinogenesis 1999
235
10

Cytochrome P450 1B1: a novel anticancer therapeutic target.
Morag C E McFadyen, Graeme I Murray. Future Oncol 2005
57
17

Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
Vasilis P Androutsopoulos, Aristidis M Tsatsakis, Demetrios A Spandidos. BMC Cancer 2009
258
10


Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
T Shimada, H Yamazaki, M Foroozesh, N E Hopkins, W L Alworth, F P Guengerich. Chem Res Toxicol 1998
170
10


Clinical importance of the cytochromes P450.
Daniel W Nebert, David W Russell. Lancet 2002
924
10


Human cytochromes P450 in health and disease.
Daniel W Nebert, Kjell Wikvall, Walter L Miller. Philos Trans R Soc Lond B Biol Sci 2013
285
10


In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues.
L Muskhelishvili, P A Thompson, D F Kusewitt, C Wang, F F Kadlubar. J Histochem Cytochem 2001
138
9

Cytochrome P450-mediated metabolism of estrogens and its regulation in human.
Yuki Tsuchiya, Miki Nakajima, Tsuyoshi Yokoi. Cancer Lett 2005
398
9

Cytochrome P450 CYP1B1 activity in renal cell carcinoma.
M C E McFadyen, W T Melvin, G I Murray. Br J Cancer 2004
43
20

CYP1B1 and hormone-induced cancer.
Ketan Gajjar, Pierre L Martin-Hirsch, Francis L Martin. Cancer Lett 2012
83
10

Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes.
Vasilis P Androutsopoulos, Athanasios Papakyriakou, Dionisios Vourloumis, Aristidis M Tsatsakis, Demetrios A Spandidos. Pharmacol Ther 2010
111
9

Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.
Sanghee Kim, Hyojin Ko, Jae Eun Park, Sungkyu Jung, Sang Kwang Lee, Young-Jin Chun. J Med Chem 2002
104
9


Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes.
Jinyun Dong, Qijing Zhang, Qing Cui, Guang Huang, Xiaoyan Pan, Shaoshun Li. ChemMedChem 2016
29
31


Cytochrome P450 pharmacogenetics and cancer.
C Rodriguez-Antona, M Ingelman-Sundberg. Oncogene 2006
395
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.